Monoclonal Antibodies (mAbs) Market Size Worth $138.6 Billion By 2024: Grand View Research, Inc.

The global monoclonal antibodies (mAbs) market was valued at USD 85.4 billion in 2015 and is expected to reach a value of USD 138.6 billion by 2024. Increasing R&D pertaining to the development of therapeutic mAbs coupled with supportive government initiatives is expected to drive the monoclonal antibodies market growth over the forecast period. Increasing demand for personalized medicine is a vital factor responsible for the increasing development of therapeutic antibodies to provide targeted therapies as every individual responds in a different manner to a particular treatment. Moreover, related benefits of using mAbs for therapeutic purposes, including fewer adverse effects, homogeneity, specificity, and large-scale production, are contributing toward significant market growth.
16 April 2018 - Article Posted by

Dhanashree Pawar

Digital Marketing
Marketing / Communications, Grand View Research (United States)

0 Reaction(s) to this article

Members who publish on this topic:

Tushar Desale

SEO Professional
Marketing / Communications, ReportBazzar (United States)
Skills and expertise:
Analytics

Questions on this topic:

  • Login to post a reaction

Please login or register

you have to loggin to be able to post a reaction


No account? Register for free
Back to Top